Resistant Hypertension in Chronic Kidney Disease

179

References

1. World Health Organization. A global brief on hypertension. WHO/DCO/WHD/2013.2. April
   3, 2013 (http://apps.who.int/iris/bitstream/10665/79059/1/WHO_DCO_WHD_2013.2_eng.
   pdf).


2. Guyton AC, Coleman TG, Cowley AW, Scheel KW, Manning RD, Norman RA. Arterial pres-
   sure regulation. Overriding dominance of the kidneys in long-term regulation and in hyperten-
   sion. Am J Med. 1972;52:584–94.


3. Lifton R, Gharavi AG, Geller DS.  Molecular mechanisms of human hypertension. Cell.
   2001;104:545–56.


4. Mu S, Shimosawa T, Ogura S, et al. Epigenetic modulation of the renal β-adrenergic-WNK4
   pathway in salt-sensitive hypertension. Nat Med. 2011;17:573–80. Nishimoto M, Fujita
   T.  Renal mechanisms of salt-sensitive hypertension: contribution of two steroid receptor-
   associated pathways. Am J Physiol Renal Physiol. 2015;308:F377–87.


5. Heer M, Baisch F, Kropp J, Gerzer R, Drummer C. High dietary sodium chloride consumption
   may not induce body fluid retention in humans. Am J  Physiol Renal Physiol. 2000;278:
   F585–95.


6. Titze J, Maillet A, Lang R. Long-term sodium balance in humans in a terrestrial space station
   simulation study. Am J  Kidney Dis. 2002;40:508–16. Rakova N, Jüttner K, Dahlmann A,
   Schröder A. Long-term space flight simulation reveals infradian rhythmicity in human Na(+)
   balance. Cell Metab. 2013;17:125–31.


7. Machnik A, Dahlmann A, Kopp C, et  al. Mononuclear phagocyte system depletion blocks
   interstitial tonicity-responsive enhancer binding protein/vascular endothelial growth factor C
   expression and induces salt-sensitive hypertension in rats. Hypertension. 2010;55:755–61.


8. Machnik A, Neuhofer W, Jantsch J, et  al. Macrophages regulate salt-dependent volume and
   blood pressure by a vascular endothelial growth factor-C-dependent buffering mechanism. Nat
   Med. 2009;15(5):545–52.


9. Oberleithner H, Peters W, Kusche-Vihrog K, et  al. Salt overload damages the glycocalyx
   sodium barrier of vascular endothelium. Pflugers Arch. 2011;462:519–28.


10. Choi HY, Park HC, Ha SK. Salt sensitivity and hypertension: a paradigm shift from kidney
    malfunction to vascular endothelial dysfunction. Electrolyte Blood Press. 2015;13(1):7–16.


11. Ball OT, Meneely GR.  Observations on dietary sodium chloride. J  Am Diet Assoc. 1957;
    33:366–70.


12. Dahl LK, Heine M, Tassinari L. Effects of chronic salt ingestion. Evidence that genetic factors
    play an important role in susceptibility to experimental hypertension. J Exp Med. 1962;115:
    1173–90.


13. Denton D, Weisinger R, Mundy NI, et al. The effect of increased salt intake on blood pressure
    of chimpanzees. Nat Med. 1995;1:1009–16.


14. MacGregor GA, Markandu ND, Best FE, et  al. Double-blind randomised crossover trial of
    moderate sodium restriction in essential hypertension. Lancet. 1982;1:351–5.


15. Intersalt Cooperative Research Group. Intersalt: an international study of electrolyte excretion
    and blood pressure. Results for 24 h urinary sodium and potassium excretion. BMJ. 1988;
    297:319–28.


16. The Trials of Hypertension Prevention Collaborative Research Group. The effects of nonphar-
    macologic interventions on blood pressure and hypertension incidence in overweight people
    with high-normal blood pressure. JAMA. 1992;267:1213–20.


17. The Trials of Hypertension Prevention Collaborative Research Group. Effects of weight loss
    and sodium reduction intervention on blood pressure and hypertension incidence in over-
    weight people with high-normal blood pressure: the trials of hypertension prevention, phase
    II. Arch Intern Med. 1997;157:657–66.


18. Whelton PK, Appel LJ, Espeland MA, et  al. for the TONE Collaborative Research Group.
    Sodium reduction and weight loss in the treatment of hypertension in older persons. A random-

11 Secondary Causes: Work-Up and Its Specificities in CKD: Influence of Volume...